A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility
A cost-benefit and cost-effectiveness analysis of Vancouver's supervised injection facility
复制标题
DOI：
10.1016/j.drugpo.2009.03.004
复制
发表时间：
2010-01-01
影响因子：
4.4
通讯作者：
Boyd, Neil
中科院分区：
文献类型：
--
作者：
Andresen, Martin A.;Boyd, Neil
背景：一个监督注射设施（SIF）已经在北美建立：Insite，在温哥华，不列颠哥伦比亚省。本文的目的是使用2008年收集和分析的二手数据对该SIF进行成本效益和成本效益分析。在使用这些数据时，我们试图确定该设施预防注射吸毒者（IDUs）感染和死亡的经济成本是否高于或低于向该社区提供这种服务（Insite）所涉及的成本。方法：利用数学模型估计每年预防的艾滋病毒新感染和死亡人数。我们将这些新感染艾滋病毒的人数和预防的死亡人数与新感染艾滋病毒的估计终生公共卫生保健费用以及。生命的价值，以便计算Insite的社会效益的可识别部分。SIF的年度运营成本被用来衡量Insite的社会成本。在使用这些信息时，我们计算了SIF的成本效益和收益成本比。结果：通过使用保守估计，温哥华SIF， Insite平均每年预防35例新的艾滋病毒病例和近3例死亡。这提供了一个社会效益：在考虑到方案费用后，每年超过600万美元，换算成平均效益-成本比为5.12:1。结论：温哥华的SIF似乎是对公共卫生保健资源的有效和高效利用，基于只有两个具体和可测量的益处的建模研究-艾滋病毒感染和过量死亡。(C) 2009 Elsevier B.V.版权所有
Background: A supervised injection facility (SIF) has been established in North America: Insite, in Vancouver, British Columbia. The purpose of this paper is to conduct a cost-effectiveness and cost-benefit analysis of this SIF using secondary data gathered and analysed in 2008. In using these data we seek to determine whether the facility's prevention of infections and deaths among injecting drug users (IDUs) is of greater or lesser economic cost than the cost involved in providing this service - Insite - to this community.Methods: Mathematical modelling is used to estimate the number of new HIV infections and deaths prevented each year. We use the number of these new HIV infections and deaths prevented, in conjunction with estimated lifetime public health care costs of a new HIV infection, and. the value of a life, in order to calculate an identifiable portion of the societal benefits of Insite. The annual costs of operating the SIF are used to measure the social costs of Insite. in using this information, we calculate cost-effectiveness and benefit-cost ratios for the SIRResults: Through the use of conservative estimates, Vancouver's SIF, Insite, on average, prevents 35 new cases of HIV and almost 3 deaths each year. This provides a societal benefit: in excess of $6 million per year after the programme costs are taken into account, translating into an average benefit-cost ratio of 5.12:1.Conclusion: Vancouver's SIF appears to be an effective and efficient use of public health care resources, based on a modelling study of only two specific and measurable benefits-HIV infection and overdose death. (C) 2009 Elsevier B.V. All rights reserved.